Considering the broader genetic background, pharmacogenomic variability may further contribute to treatment heterogeneity, as genetic variants affecting GLP-1 receptor signaling, appetite regulation, insulin secretion, and hostmicrobiota interactions could influence individual responsiveness (126)
When youre receiving highly emetogenic chemotherapy, we expect weight loss. The use of decision-support tools, such as visual aids or summary sheets, during these discussions is also beneficial
Its compelling mechanism of action involves activation of GLP-1 and glucagon receptors, thereby mimicking the weight-lowering impact of combined diet (GLP-1 suppresses appetite) and exercise (glucagon boosts energy expenditure) [3]
These tumors sometimes have the appearance of a spitzoid tumor, albeit with a prominent inflammatory infiltrate
4 Program Launch and Ongoing Support If medication is clinically appropriate, treatment may begin the same day
Key takeaways Wegovy and Trulicity are both weekly GLP-1 receptor agonist injections but have different active ingredients
